Back to Agenda
Rare Diseases Multistakeholder Collaboration Towards Regulatory Endorsed Innovative Clinical Development Approach
Session Chair(s)
Solange Corriol-Rohou, DrMed, MD, PhD
Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
AstraZeneca , France
ERDERA focuses on accelerating rare diseases drug development by combining real-world data processing, Patient Centered Outcome measures integration, a streamlined gene editing and technology transfer platforms, and innovative clinical trials designs.
Learning Objective : Identify innovative methodologies, technologies and tools for innovative therapy development; Prepare a collaboration with an innovative Rare Disease research Ecosystem and recall its funding opportunities.
Speaker(s)
Facilitator
Alexandre Betourne, PharmD, PhD
Critical Path Institute, United States
Executive Director
Have an account?